Are we Capable of Contributing to the Reduction of Eyelid Basal Cell Carcinoma? Building a Healthcare Team

Authors

  • Adriana Ribeiro Research Institute for Medicines, Faculdade de Farmácia, Universidade de Lisboa, Lisbon, Portugal. Author
  • Daniele Oliveira Research Institute for Medicines, Faculdade de Farmácia, Universidade de Lisboa, Lisbon, Portugal Author
  • Cláudia Bacalhau Department of Ophthalmology, Hospital da Luz Setúbal, Portugal Author
  • Sofia Almada Department of Ophthalmology, Hospital da Luz Setúbal, Portugal Author
  • Sílvia Diniz Department of Ophthalmology, Centro Hospitalar de Setúbal, Portugal Author
  • Ana Raquel Saramago Research Institute for Medicines, Faculdade de Farmácia, Universidade de Lisboa, Lisbon, Portugal Author
  • Helena Cabral-Marques Research Institute for Medicines, Faculdade de Farmácia, Universidade de Lisboa, Lisbon, Portugal Author
  • Diogo Sousa-Martins Research Institute for Medicines, Faculdade de Farmácia, Universidade de Lisboa, Lisbon, Portugal Author

DOI:

https://doi.org/10.47363/JORRR/2023(4)146

Keywords:

Basal Cell Carcinoma, Eyelid Basal Cell Carcinoma, Eyelid Tumour Awareness, Ophthalmology, Pharmacist, Public Health, Oculoplastic

Abstract

Background: Basal Cell Carcinoma (BCC) is the most common malignant eyelid tumour encountered by oculoplastic surgeons (ophthalmologists), contributing significantly to morbidity. The objective of this study was to assess awareness levels and knowledge among healthcare professionals and the general public, regarding eyelid BCC, with a specific focus on the following areas: risk factors, prevention habits and pharmaceutical counseling.

Methods: A cross-sectional survey study was employed for data collection. Anonymous surveys were distributed to two distinct groups: healthcare professionals (comprising physicians, pharmacists, and pharmacy students) and members of the general community in Setúbal. Data collection took place on a single day for each of these two groups.

Results: The study encompassed 201 participants, consisting of 155 (77.1%) females (mean age = 42 years-old), and 44 (21.9%) males (mean age = 46 years-old). The survey revealed that 55.2% of respondents were unaware of the typical location of eyelid BCC. Furthermore, the majority of participants expressed consensus on the importance of applying sunscreen as a preventive measure.

Conclusion: The study underscores the necessity for enhanced efforts in preventing eyelid BCC, emphasizing the crucial role of implementing protocols and educational initiatives targeting both healthcare professionals and the general public. These measures are essential to raise awareness, facilitate early detection, and enhance the management of eyelid BCC cases.

Author Biographies

  • Adriana Ribeiro, Research Institute for Medicines, Faculdade de Farmácia, Universidade de Lisboa, Lisbon, Portugal.

    Adriana Ribeiro, Research Institute for Medicines, Faculdade de Farmácia, Universidade de Lisboa, Lisbon, Portugal.

  • Daniele Oliveira, Research Institute for Medicines, Faculdade de Farmácia, Universidade de Lisboa, Lisbon, Portugal

    Daniele Oliveira, Research Institute for Medicines, Faculdade de Farmácia, Universidade de Lisboa, Lisbon, Portugal

  • Cláudia Bacalhau, Department of Ophthalmology, Hospital da Luz Setúbal, Portugal

    Cláudia Bacalhau, Department of Ophthalmology, Hospital da Luz Setúbal, Portugal

  • Sofia Almada, Department of Ophthalmology, Hospital da Luz Setúbal, Portugal

    Sofia Almada, Department of Ophthalmology, Hospital da Luz Setúbal, Portugal

  • Sílvia Diniz, Department of Ophthalmology, Centro Hospitalar de Setúbal, Portugal

    Sílvia Diniz, Department of Ophthalmology, Centro Hospitalar de Setúbal, Portugal

  • Ana Raquel Saramago, Research Institute for Medicines, Faculdade de Farmácia, Universidade de Lisboa, Lisbon, Portugal

    Ana Raquel Saramago, Research Institute for Medicines, Faculdade de Farmácia, Universidade de Lisboa, Lisbon, Portugal

  • Helena Cabral-Marques, Research Institute for Medicines, Faculdade de Farmácia, Universidade de Lisboa, Lisbon, Portugal

    Helena Cabral-Marques, Research Institute for Medicines, Faculdade de Farmácia, Universidade de Lisboa, Lisbon, Portugal

  • Diogo Sousa-Martins, Research Institute for Medicines, Faculdade de Farmácia, Universidade de Lisboa, Lisbon, Portugal

    Diogo Sousa-Martins, Research Institute for Medicines, Faculdade de Farmácia, Universidade de Lisboa, Lisbon, Portugal 

Downloads

Published

2023-10-02